• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

电化学法检测蛋白酶体 20S 活性及其抑制剂与抗癌药物的相互作用

Electrochemical assay for 20S proteasome activity and inhibition with anti-cancer drugs.

机构信息

Laboratory of Electroanalysis and Corrosion, Instituto Pedro Nunes, 3030-199 Coimbra, Portugal.

National Institute of Material Physics, Atomistilor 405A, 077125 Magurele, Romania.

出版信息

Talanta. 2019 Jul 1;199:32-39. doi: 10.1016/j.talanta.2019.02.052. Epub 2019 Feb 12.

DOI:10.1016/j.talanta.2019.02.052
PMID:30952265
Abstract

The majority of eukaryotic regulated protein turnover is performed by the proteasome, a multi-catalytic enzyme. Due to the fact that proteasome enzyme abnormal functioning was observed in different malignant cells, the proteasome is becoming a target for medical treatment. In order to evaluate the mechanisms of action of pharmaceutical compounds on proteasome enzyme inhibition, detecting and characterizing its activity is essential. An electrochemical assay that allows the monitoring of the chymotrypsin-like activity and inhibition of the 20S proteasome enzyme, based on the electrochemical detection of an electroactive compound released upon proteolysis of an adequate chymotrypsin-substrate is described. By employing differential pulse voltammetric measurement, the activity of the 20S proteasome enzyme was investigated for different incubation times of 20S with oligopeptide substrate as well as for different concentrations of substrate. Enzyme kinetic parameters were determined by voltammetry and the electrochemical assay compared with fluorescence spectroscopy. Electrochemical quartz crystal microbalance and atomic force microscopy were also used to investigate substrate interaction with the 20S proteasome and their adsorption at the electrode surface. Finally, the new electrochemical assay allowed to investigate the mechanisms of two different proteasome inhibitor drugs, bortezomib and oprozomib, underlying the applicability of the assay for understanding proteasome inhibitor action.

摘要

大多数真核生物调节蛋白的降解是由蛋白酶体完成的,它是一种多催化酶。由于在不同的恶性细胞中观察到蛋白酶体酶的异常功能,因此蛋白酶体正在成为治疗的靶点。为了评估药物化合物对蛋白酶体酶抑制作用的作用机制,检测和表征其活性是必不可少的。本文描述了一种基于电活性化合物在适当的胰凝乳蛋白酶底物的蛋白水解作用下释放的电化学测定,用于监测糜蛋白酶样活性和 20S 蛋白酶体酶抑制的电化学测定。通过采用差分脉冲伏安法测量,研究了 20S 与寡肽底物孵育不同时间以及不同底物浓度时的酶活性。通过伏安法和电化学测定确定了酶动力学参数,并将电化学测定与荧光光谱法进行了比较。电化学石英晶体微天平和原子力显微镜也用于研究底物与 20S 蛋白酶体的相互作用及其在电极表面的吸附。最后,新的电化学测定法允许研究两种不同的蛋白酶体抑制剂药物硼替佐米和奥普佐米的作用机制,证明了该测定法在理解蛋白酶体抑制剂作用方面的适用性。

相似文献

1
Electrochemical assay for 20S proteasome activity and inhibition with anti-cancer drugs.电化学法检测蛋白酶体 20S 活性及其抑制剂与抗癌药物的相互作用
Talanta. 2019 Jul 1;199:32-39. doi: 10.1016/j.talanta.2019.02.052. Epub 2019 Feb 12.
2
Disulfiram is a slow-binding partial noncompetitive inhibitor of 20S proteasome activity.双硫仑是一种20S蛋白酶体活性的慢结合型部分非竞争性抑制剂。
Arch Biochem Biophys. 2017 Nov 1;633:23-28. doi: 10.1016/j.abb.2017.09.003. Epub 2017 Sep 5.
3
The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design.人源 20S 蛋白酶体的抑制机制使新一代抑制剂的设计成为可能。
Science. 2016 Aug 5;353(6299):594-8. doi: 10.1126/science.aaf8993.
4
Discovery of novel 20S proteasome inhibitors by rational topology-based scaffold hopping of bortezomib.通过基于拓扑结构的硼替佐米合理骨架跃迁发现新型20S蛋白酶体抑制剂。
Bioorg Med Chem Lett. 2018 Jul 1;28(12):2148-2152. doi: 10.1016/j.bmcl.2018.05.018. Epub 2018 May 9.
5
Progress curve analysis of the kinetics of slow-binding anticancer drug inhibitors of the 20S proteasome.20S蛋白酶体慢结合抗癌药物抑制剂动力学的进展曲线分析
Arch Biochem Biophys. 2018 Feb 1;639:52-58. doi: 10.1016/j.abb.2017.12.020. Epub 2018 Jan 2.
6
An antibody-based amperometric biosensor for 20S proteasome activity and inhibitor screening.一种基于抗体的用于20S蛋白酶体活性检测及抑制剂筛选的安培型生物传感器。
Analyst. 2021 May 21;146(10):3216-3224. doi: 10.1039/d0an02426k. Epub 2021 Apr 7.
7
Proteasome Inhibitors Bortezomib and Carfilzomib Stimulate the Transport Activity of Human Organic Anion Transporter 1.蛋白酶体抑制剂硼替佐米和卡非佐米刺激人有机阴离子转运蛋白 1 的转运活性。
Mol Pharmacol. 2020 Jun;97(6):384-391. doi: 10.1124/mol.119.118653. Epub 2020 Mar 31.
8
Immunoproteasome-selective inhibitors: An overview of recent developments as potential drugs for hematologic malignancies and autoimmune diseases.免疫蛋白酶体选择性抑制剂:作为血液系统恶性肿瘤和自身免疫性疾病潜在药物的最新研究进展概述。
Eur J Med Chem. 2019 Nov 15;182:111646. doi: 10.1016/j.ejmech.2019.111646. Epub 2019 Aug 29.
9
Bortezomib Inhibits Open Configurations of the 20S Proteasome.硼替佐米抑制 20S 蛋白酶体的开放构象。
J Am Soc Mass Spectrom. 2024 Jun 5;35(6):1063-1068. doi: 10.1021/jasms.4c00080. Epub 2024 May 15.
10
Design, synthesis and biological evaluation of novel non-peptide boronic acid derivatives as proteasome inhibitors.新型非肽硼酸衍生物作为蛋白酶体抑制剂的设计、合成及生物学评价
Eur J Med Chem. 2017 Mar 10;128:180-191. doi: 10.1016/j.ejmech.2017.01.034. Epub 2017 Jan 23.

引用本文的文献

1
Immobilized Antibodies on Mercaptophenylboronic Acid Monolayers for Dual-Strategy Detection of 20S Proteasome.基于巯基苯硼酸单层固定化抗体的 20S 蛋白酶体双重策略检测
Sensors (Basel). 2021 Apr 12;21(8):2702. doi: 10.3390/s21082702.